Related references
Note: Only part of the references are listed.APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice
Saman Soleimanpour et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses
Vijaya B. Joshi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Cellular and Humoral Mechanisms Involved in the Control of Tuberculosis
Joaquin Zuniga et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70
Majid Tebianian et al.
BIOLOGICALS (2011)
A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
Sucharitha Balu et al.
JOURNAL OF IMMUNOLOGY (2011)
Chitosan-based delivery systems for protein therapeutics and antigens
Maryam Amidi et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists
Matthew Black et al.
EXPERT REVIEW OF VACCINES (2010)
Nasal vaccine innovation
Inderjit Jabbal-Gill
JOURNAL OF DRUG TARGETING (2010)
Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis
Liliana Encinales et al.
MOLECULAR IMMUNOLOGY (2010)
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen
Bram Slutter et al.
VACCINE (2010)
The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine
Fabienne Rauw et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2010)
Induction of Th1-Type Immune Response by Chitosan Nanoparticles Containing Plasmid DNA Encoding House Dust Mite Allergen Der p 2 for Oral Vaccination in Mice
Guoping Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination
Bram Slutter et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Evaluation of Properties of Chitosan as an Adjuvant for Inactivated Influenza Vaccines Administered Parenterally
Yuri Ghendon et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Sai T. Reddy et al.
TRENDS IN IMMUNOLOGY (2006)
Advances in tuberculosis vaccine strategies
Yasir A. W. Skeiky et al.
NATURE REVIEWS MICROBIOLOGY (2006)
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
S Gelperina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration
C Porporatto et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu
ZK Carpenter et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery
T Nagamoto et al.
PHARMACEUTICAL RESEARCH (2004)
Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan
EA McNeela et al.
VACCINE (2004)
Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation
M Huang et al.
PHARMACEUTICAL RESEARCH (2004)
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
A Vila et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy
P Strong et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres
I Gutierro et al.
VACCINE (2002)
Tuberculosis vaccines
DB Young et al.
BRITISH MEDICAL BULLETIN (2002)
Chitosan as a novel nasal delivery system for vaccines
L Illum et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
ESAT-6 subunit vaccination against Mycobacterium tuberculosis
L Brandt et al.
INFECTION AND IMMUNITY (2000)
Share Paper
